JAG1 and Alzheimer disease: In particular, we found a downregulation of the master regulator of cell differentiation JAG1, a Notch ligand, as well as an upregulation of proinflammatory factors such as CSF2 (GM-CSF) and CSF3 (G-CSF) in the AD-MSCs of SSc patients.